6 March 2017
EU Finalizes New Medical Device Regulations (MDR) which update the regulatory framework for the marketing of devices and IVDs in Europe
EU Council will vote the MDR adoption on March 7, 2017.
6 February 2017
BioVentrix Announces NUB Reimbursement Status 1 for Revivent TC™ TransCatheter Ventricular Enhancement System in Germany
NUB Status 1 is the highest priority designation available, and was only assigned to a small minority of product submissions for 2017.
2 January 2017
Boston Scientific Closes Acquisition of Neovasc Advanced Biological Tissue Capabilities, Acquires 15% Stake
Boston Scientific Corporation announced the close of its acquisition of certain manufacturing assets and capabilities of the Neovasc, advanced biological tissue business
30 November 2016
RENASCENT-III Trial investigates 100-Micron MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold
Amaranth Medical announces the trial initiation in Italy and Colombia
March 17-19, 2017
66th Annual Scientific Session – ACC 2017 – Washington
Meet us in Washington, US
